Global CBD (Cannabidiol) Market is expected to undergo a CAGR of 38.90% during the forecast period. This indicates that the market value, which was USD 9.86 billion in 2022, would rocket up to USD 136.64 billion by 2032.
The cannabis plant, including hemp and marijuana, contains a substance called cannabidiol. It provides a number of health advantages, including easing the symptoms of cancer, curing skin conditions, assisting in the lowering of blood pressure, and reducing inflammation and pain. Delta-9-tetrahydrocannabinol (THC), the primary active component of cannabidiol, is one of approximately 80 compounds found in the cannabis sativa plant. Due to the fact that cannabidiol has been shown to be useful in the development of novel medications that cure a variety of illnesses. Only “cosmetic” goods with a THC content of less than 0.3% are permitted to contain cannabidiol. Products made from hemp that contains cannabidiol are mostly used to treat ailments including seizure disorders, anxiety, pain, dystonia, Parkinson’s disease, Crohn’s disease, and many more.
Chronic pain from injuries can be effectively treated with cannabidiol (CBD) oil. Additionally, it works well to treat insomnia, anxiety, and inflammation. Along with regulating mood, pain, and memory, it aids in enhancing an individual’s physiological and cognitive processes. One of the 113 cannabinoids found in cannabis plants, cannabidiol (CBD) makes up up to 40% of the plant’s extract.
Access The Free Sample Report: https://analyticsmarketresearch.com/sample-request/cbd-(cannabidiol)-market/137/
Drivers
- Market growth was impacted by growth and expansion.
The direct and indirect growth of this market was aided by the rise and expansion of the personal care and cosmetics industries. This is due to the fact that cannabidiol is useful for treating skin disorders including eczema and psoriasis as well as swelling, discomfort, and redness brought on by ongoing outbreaks.
- Increasing understanding of how to control market supply and demand
Small and medium-sized businesses are using cannabidiol more frequently as a result of growing public awareness of its therapeutic effects. Additionally, hemp oil is widely used in the pharmaceutical industry since it eases physical pain, which is a good indicator. This is supporting the market’s expansion in turn.
Epilepsy prevalence is increasing, and the FDA has recently approved more marijuana-based medications for use in treating it.
Epilepsy condition is becoming more common as a result of the increased usage of marijuana in the production of pharmaceutical medications used to treat it. Due to the increase in epilepsy instances worldwide, several major manufacturers have introduced a marijuana-based product to treat epilepsy. Epilepsy became the most prevalent neurological disorder in 2022, when there were an estimated 50 million cases worldwide, according to the World Health Organization. As a result, there was an enormous increase in demand for medical marijuana.
Major Players
- Hempura CBD
- Love CBD
- Folium Biosciences
- Holistic Hemp
- Aura CBD
- Hemp Botanics
- Good Hemp
- Aphria Inc.
- Elixinol
- Green Roads of Florida, LLC
- PureKana
- CBD Brothers
- CBD Life UK
- Provacan
Types
- Food Grade
- Pharmaceutical Grade
Applications
- Food & Beverage
- Healthcare
Read This Complete Strategic Report: https://analyticsmarketresearch.com/reports/cbd-(cannabidiol)-market/137/
Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global CBD (Cannabidiol) market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
The CBD (Cannabidiol) market report is a perfect foundation for people looking out for a comprehensive study and analysis of the CBD (Cannabidiol) market. On the basis of historic growth analysis and current scenario of CBD (Cannabidiol) market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global CBD (Cannabidiol) market. This further helps user with their developmental strategy.
This report examines all the key factors influencing growth of global CBD (Cannabidiol) market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global CBD (Cannabidiol) market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.
